Seres Therapeutics Inc
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1,055.9 | 1.7 | 1.1 | 31.2 | 23.2 | – | – | |
| 26.4 | 18.4 | 20.7 | 20.7 | 20.2 | 12.8 | 9.0 | 10.1 | 15.0 | 6.5 | 9.0 | 3.7 | 7.5 | 7.1 | 7.2 | 12.2 | 101.6 | 67.5 | 61.3 | 73.1 | 4.3 | 5.3 | 4.7 | 2.3 | 58.6 | 98.4 | 140.3 | 4.8 | 2.4 | 1.4 | 0.9 | 291.7 | 2,265.9 | 24.1 | 20.5 | 16.3 | 26.7 | 167.5 | 74.4 | 40.5 | |
| 3.2 | 3.0 | 4.1 | 5.2 | 7.6 | 6.8 | 29.6 | – | – | – | – | – | – | – | – | – | 12.6 | 12.8 | 13.1 | 21.7 | 3.8 | 5.8 | 8.1 | 13.6 | 11.6 | 65.0 | – | 27.6 | – | – | – | – | 6.1 | 10.4 | 2.4 | 2.9 | 3.9 | 3.0 | 3.2 | 2.2 | |
| 24.3 | 16.2 | 19.1 | 19.5 | 19.0 | 11.9 | 7.8 | 8.7 | 12.9 | 3.9 | 8.1 | 1.3 | 6.4 | 6.1 | 6.5 | 11.1 | 94.0 | 64.9 | 60.2 | 71.7 | 3.0 | 4.2 | 4.0 | 1.8 | 47.6 | 83.2 | 132.7 | 3.8 | 1.9 | 1.3 | 0.9 | 399.9 | 1,352.2 | 20.4 | 12.1 | 10.3 | 20.7 | 122.7 | 57.8 | 38.5 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 13.5 | 8.8 | – | – | |
| 13.7 | 17.8 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 20.5 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 152.8 | – | – | |
| 7.3% | 5.6% | -22.7% | -21.6% | -13.2% | -19.6% | -27.0% | -22.7% | -31.9% | -35.2% | -24.6% | -38.4% | -18.0% | -31.8% | -27.3% | -23.7% | -3.8% | -4.2% | -5.3% | -5.3% | 4.9% | -0.4% | -6.3% | -16.3% | -30.1% | -34.0% | -34.8% | -21.4% | -43.3% | -69.3% | -71.1% | -169.3% | -109.2% | -103.8% | -71.2% | -62.2% | -13.9% | 0.7% | -49.7% | -67.3% | |
| Margins | ||||||||||||||||||||||||||||||||||||||||
| -303.8% | -276.7% | -292.9% | -296.7% | -167.0% | -178.7% | -180.7% | -170.6% | -360.2% | -239.5% | -201.7% | -125.7% | -123.6% | -132.3% | -61.9% | -36.2% | 9.6% | 25.1% | -76.2% | -200.8% | 16.3% | 2.1% | -8.2% | -17.2% | -1,122.2% | -2,325.9% | -3,366.5% | -38.1% | -11.6% | 24.2% | 43.8% | -6,843.3% | -34,771.9% | -460.7% | -192.7% | -186.6% | -360.0% | -423.8% | -20.9% | 82.6% | |
| -464.2% | -426.5% | -447.7% | -448.7% | -272.1% | -284.7% | -283.7% | -269.8% | -523.8% | -354.8% | -305.4% | -200.8% | -198.2% | -208.3% | -189.5% | -265.2% | -384.2% | -265.3% | -337.5% | -438.4% | -21.2% | -44.5% | -60.4% | -73.3% | -1,701.9% | -3,458.1% | -5,110.6% | -113.9% | -105.3% | -83.2% | -54.4% | -39,417.4% | -206,257.8% | -2,036.2% | -1,915.3% | -1,848.3% | -1,639.4% | -11,910.1% | -7,641.0% | -4,462.8% | |
| -458.9% | -420.8% | -441.1% | -441.4% | -267.2% | -278.4% | -277.8% | -264.3% | -515.2% | -350.0% | -301.6% | -198.1% | -194.0% | -203.7% | -186.1% | -262.3% | -385.2% | -268.3% | -340.6% | -441.6% | -21.8% | -45.2% | -61.6% | -75.5% | -1,729.9% | -3,509.5% | -5,177.1% | -117.7% | -111.0% | -90.0% | -65.2% | -43,343.6% | -39,804.7% | 2.3% | 1,224.4% | 1,442.9% | 85.5% | 721.9% | -4,088.8% | -1,192.9% | |
| 192.8% | 103.1% | -468.9% | -446.3% | -266.2% | -249.8% | -242.1% | -229.3% | -478.1% | -229.2% | -220.7% | -140.4% | -134.3% | -225.9% | -196.7% | -288.1% | -389.9% | -283.6% | -327.6% | -391.1% | 20.9% | -2.0% | -29.4% | -37.5% | -1,762.6% | -3,347.9% | -4,887.4% | -102.1% | -104.8% | -99.2% | -63.0% | -49,367.9% | -247,489.1% | -2,500.7% | -1,457.1% | -1,013.3% | -370.4% | 109.6% | -3,694.1% | -2,724.1% | |
| Returns | ||||||||||||||||||||||||||||||||||||||||
| -55.8% | -69.0% | -87.3% | -110.8% | -100.2% | -147.3% | -915.2% | – | – | – | – | – | – | – | – | – | -47.7% | -51.0% | -72.9% | -130.9% | -19.2% | -49.9% | -107.1% | -447.3% | -342.3% | -2,319.9% | – | -678.4% | – | – | – | – | -106.5% | 1.0% | 144.6% | 260.9% | 12.3% | 12.9% | -177.0% | -65.0% | |
| -28.9% | -33.6% | -39.8% | -45.0% | -40.4% | -47.2% | -57.6% | -68.9% | -97.8% | -82.1% | -89.1% | -53.6% | -58.6% | -53.1% | -59.5% | -75.3% | -25.2% | -26.0% | -34.3% | -49.1% | -8.5% | -18.5% | -27.1% | -37.8% | -74.2% | -71.7% | -98.0% | -37.8% | -38.4% | -31.7% | -24.2% | -50.4% | -14.3% | 0.1% | 44.4% | 59.8% | 3.8% | 4.1% | -39.9% | -22.1% | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||||
| -40 | -47 | -35 | -27 | -39 | -27 | -38 | -47 | -44 | -74 | -26 | -93 | -41 | -36 | -25 | -32 | -177 | -86 | -36 | -43 | -196 | -149 | -96 | -69 | -147 | -108 | -39 | -123 | -62 | -21 | -0.3 | 40 | -58 | -22 | -50 | -36 | -38 | -35 | -19 | -3.8 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -3.9 | -3.2 | – | – | |
| 51.8% | 48.6% | 45.5% | 40.6% | 40.4% | 32.0% | 6.3% | -10.0% | -28.0% | -39.9% | -65.2% | -12.3% | -26.0% | -36.5% | -55.7% | -65.1% | 52.8% | 51.0% | 47.0% | 37.5% | 44.3% | 37.1% | 25.3% | 8.4% | 21.7% | 3.1% | -17.7% | 5.6% | -4.1% | -12.5% | -17.5% | -27.1% | 13.4% | 9.9% | 30.7% | 22.9% | 30.5% | 32.0% | 22.5% | 34.0% | |
| 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.9 | – | – | – | – | – | – | – | – | – | 0.2 | 0.2 | 0.2 | 0.3 | 0.2 | 0.2 | 0.7 | 2.5 | 0.9 | 5.1 | – | 4.7 | – | – | – | – | 0.3 | 0.6 | 0.2 | 0.3 | 0.2 | 0.2 | 0.4 | 0.3 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||||
| -42.72 | -45.37 | -48.23 | -48.25 | -42.33 | -44.06 | -45.20 | -45.05 | -52.25 | -48.34 | -46.48 | -34.70 | -20.81 | -20.04 | -18.59 | -20.68 | -21.47 | -19.49 | -22.88 | -28.87 | -7.13 | -14.27 | -18.82 | -22.36 | -37.76 | -39.95 | -42.06 | -23.63 | -22.02 | -17.60 | -11.32 | -21.40 | -3.34 | 0.02 | 8.37 | 9.83 | 0.61 | 0.64 | -4.89 | -2.33 | |
| 9.31 | 10.78 | 10.93 | 10.93 | 15.84 | 15.82 | 16.27 | 17.05 | 10.14 | 13.81 | 15.41 | 17.52 | 10.73 | 9.84 | 9.99 | 7.88 | 5.57 | 7.26 | 6.72 | 6.54 | 32.70 | 31.54 | 30.53 | 29.63 | 2.18 | 1.14 | 0.81 | 20.08 | 19.84 | 19.55 | 17.36 | 0.05 | 0.01 | 0.69 | 0.68 | 0.68 | 0.72 | 0.09 | 0.12 | 0.20 | |
| 76.55 | 65.71 | 55.22 | 43.54 | 42.23 | 29.92 | 4.94 | -6.52 | -14.98 | -23.47 | -34.04 | -7.96 | -9.21 | -13.78 | -17.41 | -17.89 | 45.03 | 38.21 | 31.40 | 22.05 | 37.02 | 28.62 | 17.57 | 5.00 | 11.03 | 1.72 | -7.61 | 3.48 | -2.36 | -6.94 | -8.18 | -11.49 | 3.13 | 1.59 | 5.79 | 3.77 | 4.98 | 4.99 | 2.77 | 3.58 | |
| 17.95 | 11.11 | -51.27 | -48.79 | -42.18 | -39.54 | -39.39 | -39.08 | -48.50 | -31.65 | -34.01 | -24.60 | -14.41 | -22.23 | -19.65 | -22.71 | -21.73 | -20.60 | -22.01 | -25.57 | 6.83 | -0.63 | -8.99 | -11.11 | -38.48 | -38.11 | -39.71 | -20.50 | -20.78 | -19.39 | -10.95 | -24.37 | -20.75 | -17.22 | -9.96 | -6.90 | -2.66 | 0.10 | -4.42 | -5.32 | |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.